Skip to record
EnterprisesBriaCell Therapeutics Corp.

BriaCell Therapeutics Corp.

Enterprise record · Agent view

Version public-1

Agent view

Machine access

Formats and access paths for the same published Governance Record shown in Human View.

alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790 · public-1

Formats

https://registry.alpha.ac/companies/briacell-therapeutics-corp.md

Open in new tabDownload
# BriaCell Therapeutics Corp.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1 |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/briacell-therapeutics-corp |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 18 |
| Claims under review | 1 |
| Evidence records | 7 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-04T04:48:06.915082+00:00 |
| Last reviewed | 2026-10-04T04:48:06.915082+00:00 |

## Identity

- Legal name: BriaCell Therapeutics Corp.
- Display name: BriaCell Therapeutics Corp.

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- Claim alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:11: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:dr-vaughn-c-embro-pantalony","name":"Dr. Vaughn C. Embro-Pantalony"},"source_id":"board_seats"}`
- Claim alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:12: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:dr-jane-gross","name":"Dr. Jane Gross"},"source_id":"board_seats"}`
- Claim alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:13: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:mr-martin-schmieg","name":"Martin E. Schmieg"},"source_id":"board_seats"}`
- Claim alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:mr-martin-schmieg","name":"Martin E. Schmieg"},"source_id":"board_seats"}`
- Claim alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:dr-vaughn-c-embro-pantalony","name":"Dr. Vaughn C. Embro-Pantalony"},"source_id":"board_seats"}`
- Claim alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:mr-jamieson-bondarenko","name":"Mr. Jamieson Bondarenko"},"source_id":"board_seats"}`
- Claim alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:dr-rebecca-taub","name":"Dr. Rebecca Taub"},"source_id":"board_seats"}`

## Leadership

- Martin E. Schmieg: Director, Audit; Compensation · Chair. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:5. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:122edb2683a961e7bb4b9355c2e0cef0a1f73d61080460852d8f6dd3a122642c.
- Gadi Levin, CA, MBA: Chief Financial Officer and Corporate Secretary. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:6. Valid from: 2025-10-16. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f0f54f2047e2fb704c660bbcd358a1d2a4a4dd7ca3d16c0423abd577a9d4540f.
- Giuseppe Del Priore, MD, MPH: Chief Medical Officer. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:7. Valid from: 2025-10-16. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:27429acc03a62e58fb0c7fe26f9722737eeda1cf0b1c8a0060f7b2e2c52e788a.
- Miguel A. Lopez-Lago, PhD: Chief Scientific Officer. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:8. Valid from: 2025-10-16. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:66139f3670f4d313f95ce0b550a5f0292cb3513e7f9646bd25026e7b30d026da.
- William V. Williams, MD, FRCP: President, Chief Executive Officer, and Director. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:9. Valid from: 2025-10-16. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6104398cd9020884a8ebe06c772e263ecf65b20ac68eb973c945c032c95009d5.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- Audit: Chair Dr. Vaughn C. Embro-Pantalony; Members Dr. Vaughn C. Embro-Pantalony (Chair); Dr. Jane Gross; Martin E. Schmieg. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_record:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d.
- Compensation: Chair Martin E. Schmieg; Members Martin E. Schmieg (Chair); Dr. Vaughn C. Embro-Pantalony. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_record:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d.
- Nominating and Governance: Chair Mr. Jamieson Bondarenko; Members Mr. Jamieson Bondarenko (Chair); Dr. Rebecca Taub. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_record:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d.

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- BriaCell Therapeutics Corp.. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a86d1000f650ec879b562d31bcdd731cad0481dfe44692a263b607130eaf7bf0.

## Entity Status

- Public listing published. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a86d1000f650ec879b562d31bcdd731cad0481dfe44692a263b607130eaf7bf0.

## Published Fact

- US. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a86d1000f650ec879b562d31bcdd731cad0481dfe44692a263b607130eaf7bf0.

## Committee Appointment

- Dr. Vaughn C. Embro-Pantalony: chair, Audit. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d.
- Dr. Jane Gross: member, Audit. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d.
- Martin E. Schmieg: member, Audit. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d.
- Martin E. Schmieg: chair, Compensation. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d.
- Dr. Vaughn C. Embro-Pantalony: member, Compensation. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d.
- Mr. Jamieson Bondarenko: chair, Nominating and Governance. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d.
- Dr. Rebecca Taub: member, Nominating and Governance. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:a86d1000f650ec879b562d31bcdd731cad0481dfe44692a263b607130eaf7bf0: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/briacell-therapeutics-corp).
- alpha:projection-evidence:document:122edb2683a961e7bb4b9355c2e0cef0a1f73d61080460852d8f6dd3a122642c: [BriaCell Therapeutics Corp. DEF 14A 2026-02-12](https://www.sec.gov/Archives/edgar/data/1610820/000149315226006390/formdef14a.htm).
- alpha:projection-evidence:document:f0f54f2047e2fb704c660bbcd358a1d2a4a4dd7ca3d16c0423abd577a9d4540f: [BCTXZ 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1610820/000149315225018212/form10-k.htm).
- alpha:projection-evidence:document:27429acc03a62e58fb0c7fe26f9722737eeda1cf0b1c8a0060f7b2e2c52e788a: [BCTXL 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1610820/000149315225018212/form10-k.htm).
- alpha:projection-evidence:document:66139f3670f4d313f95ce0b550a5f0292cb3513e7f9646bd25026e7b30d026da: [BCTXZ 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1610820/000149315225018212/form10-k.htm).
- alpha:projection-evidence:document:6104398cd9020884a8ebe06c772e263ecf65b20ac68eb973c945c032c95009d5: [BCTXL 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1610820/000149315225018212/form10-k.htm).
- alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d: [Audit](https://www.sec.gov/Archives/edgar/data/1610820/000149315226006390/formdef14a.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/briacell-therapeutics-corp)
- [Public Markdown](https://registry.alpha.ac/companies/briacell-therapeutics-corp.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=jsonld)
- MCP resource: `alpha://companies/briacell-therapeutics-corp` at https://mcp.alpha.ac/mcp


## Connected governance records

Structured intelligence is not currently available. Existing published profile evidence remains accessible.

Connect

REST

MCP tools

Server card: Alpha Terminal · alpha://companies/briacell-therapeutics-corp

  • find_person

    Search Alpha's permission-safe public Profile directory. Returns canonical Alpha person IDs, evidence-backed current roles, assurance state, review time, and limitations. Similar names remain separate candidates.

  • get_claim_evidence

    Retrieve the public source evidence for one permissioned Alpha Profile claim. Returns source tier, URLs, validity, confidence, review time, and limitations.

  • get_company_profile

    Retrieve a public Alpha Company Profile with canonical company identity, active listings, current confirmed board and executive roles, source evidence, explicit permissions, as-of time, and limitations. Private relationships, company administration, and unpublished ratings are excluded.

  • get_current_roles

    Retrieve the current confirmed company and board roles from a public Alpha Profile. Every role includes available source evidence, confidence, verification state, and validity.

  • get_executive_profile

    Retrieve a public Alpha Profile with canonical identity, current verified roles, permissioned claims, claim-level evidence, assurance state, as-of time, and limitations. Private contact, Council activity, and relationships are excluded.

  • get_platform_stats

    Get Alpha platform statistics and data coverage. Returns counts of companies, directors, ratings, filings, and regulations in the Alpha intelligence database.

A2A

Agent card

Follow

Recent Registry updates (general index)

Record-specific changes feed and webhook events: Proposed. No delivery endpoint is published for this record.

Cite

URL
https://registry.alpha.ac/companies/briacell-therapeutics-corp
Version
public-1
JSON content hash
Unavailable

Evidence sources

  • Alpha canonical company public projection
  • BriaCell Therapeutics Corp. DEF 14A 2026-02-12
  • BCTXZ 10-K executive officers
  • BCTXL 10-K executive officers
  • BCTXZ 10-K executive officers
  • BCTXL 10-K executive officers
  • Audit